AIDS Funding Shifts to the Laboratory
WASHINGTON--William Paul, MD, director of the NIH Office of AIDS Research, has announced that AIDS funding will begin to shift away from clinical research toward investigator-initiated laboratory research. He said that continuation of past policies will result in only "slow, fitful progress."
WASHINGTON--William Paul, MD, director of the NIH Office of AIDSResearch, has announced that AIDS funding will begin to shiftaway from clinical research toward investigator-initiated laboratoryresearch. He said that continuation of past policies will resultin only "slow, fitful progress."
Dr. Paul appointed a new task force, chaired by Arnold Levine,a Princeton University molecular biologist, to determine researchpriorities.
Articles in this issue
First Results of Avicidin Trials
Chemo Patients Often Develop Menstrual Irregularities
Growth Factor Receptor Blockade Moving From Laboratory to Clinic
Controlled-Release AZT Gets FDA Go-Ahead for New Drug Investigation
Vinorelbine Plus Chemo Promising in Advanced Disease
Bone Substudy a Part of Tamoxifen Prevention Trial
Ultrasound Breast Screens Useful in Selected Women
New Roles Forecast for Endocrine Therapy
Antisense Drug Against BCL-2 Effective in Animal Cancer Models
Anticancer Drugs From Zeneca in Regulatory Phase of Development
Osteosarcoma Chemo Regimens Debated
Primary Chemotherapy Allows Breast-Conserving Surgery in French Study
Cancer Care, Inc. Sponsors Make-Up Clinics for Chemo Patients
$2 Billion Budget for NCI Proposed
Risk of Gyn Cancer Increases After Diagnosis of Breast Cancer
